Van Doorn, R <br/><br/>
Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor.  [electronic resource] 

 -  The British journal of dermatology  Sep 2002 
 - 598-601 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0007-0963 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2133.2002.04864.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acneiform Eruptions--chemically induced<br/>Antineoplastic Agents--adverse effects<br/>Drug Eruptions--etiology<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib<br/>Humans<br/>Male<br/>Middle Aged<br/>Quinazolines--adverse effects